Daxor (DXR)

• Market cap: $40.4M
• 1 day: 2.58%
• 5 days: 2.96%
• 1 month: -7.53%
• 3 months: -10.70%
• 6 months: -8.34%
• Year to date: -12.11%
• 1 year: 4.37%
• 5 years: -12.93%
• 10 years: 25.75%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Employees: 750

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

50% more funds holding

Funds holding: 6 [Q2] → 9 (+3) [Q3]

2% more capital invested

Capital invested by funds: $740K [Q2] → $757K (+$16.2K) [Q3]

0.16% more ownership

Funds ownership: 1.64% [Q2] → 1.8% (+0.16%) [Q3]

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2